NCT04066218

Brief Summary

This is a qualitative research study involving semistructured interviews and Think-Aloud methodology during completion of a clinical screening tool. All participants will undergo the same semistructured interviews.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2019

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 26, 2019

Completed
21 days until next milestone

Study Start

First participant enrolled

September 16, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 7, 2020

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

June 30, 2022

Status Verified

June 1, 2022

Enrollment Period

7 months

First QC Date

August 21, 2019

Last Update Submit

June 29, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Describe AYA CCS perspectives on implementation of screening for sexual dysfunction, including preferred modality, setting and timing for evaluating sexual dysfunction.

    Qualitative interviews will be conducted by phone by a trained qualitative research interviewer. Interviews will be in-depth and semistructured, utilizing a combination of broad, open-ended questions and more specific probes. The interview guide was developed with the help of Dr. Michael Fisher, PhD, who has expertise in qualitative research methodology. The interviewer will take detailed field notes. This portion of the interview will last approximately 25-35 minutes and will be digitally recorded and professionally transcribed. After each interview, the interviewer will complete an Interview Summary Form, which will serve as a memoing tool and summarize initial themes or impressions that may be relevant to the research question.

    1 year

Secondary Outcomes (1)

  • Assess AYA CCS perceptions of the PROMIS SexFS Brief, an existing adult clinical screening tool for sexual dysfunction, in a qualitative pilot study.

    1 year

Study Arms (2)

age 15-19

The investigators plan to complete 24 interviews with 12 in the age 15-19 cohort.The investigators will also ensure that at least 8 people from each sex are included in this study.

Other: Interviews

age 20-24

The investigators plan to complete 24 interviews with 12 in the age 20-24 cohort. The investigators will also ensure that at least 8 people from each sex are included in this study.

Other: Interviews

Interventions

* Participation will serve as verbal consent. * Qualitative PRA will call participant to schedule either phone or in person interview. If via phone, the study PRA performing the interview, will remind them to find a private space to speak. * REDCap link will be sent for PROMIS SexFS Brief. * PRA will perform semistructured interview and guide Think-Aloud to complete the PROMIS SexFS Brief. * Participants will not submit responses to PROMIS SexFS Brief responses after completing the tool.

age 15-19age 20-24

Eligibility Criteria

Age15 Years - 24 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

* Sample size * Max number of participants that can be enrolled is 30 * Max number of participants that can be interviewed is 24 * Gender Male and Female * Age Range 15-24 * Demographic group English-speaking * General health status Pediatric cancer survivors (diagnosed at \<18 years of age and now at least 2 years off therapy) * Geographic location Children's Hospital Colorado and University of Colorado Hospital

You may qualify if:

  • Ability to read and understand the postcard consent.
  • Stated willingness to comply with all study procedures and be available for the duration of the study.
  • Age 15-24 at time of enrollment
  • History of cancer diagnosis, diagnosed at \<18 years old
  • Off therapy (chemotherapy, surgery, radiation) for a minimum of 2 years
  • Sufficient cognitive functioning such that participants are able to complete study measures, as determined by their physician and research personnel.

You may not qualify if:

  • Developmental or intellectual disability, as determined by the patient's physician
  • Received neither chemotherapy nor radiation therapy
  • Non-English speaking
  • Non-English reading

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Children's Hospital Colorado

Aurora, Colorado, 80045, United States

Location

Colorado School of Public Health, University of Colorado Denver

Aurora, Colorado, 80045, United States

Location

MeSH Terms

Conditions

NeoplasmsSexual Dysfunction, Physiological

Interventions

Interviews as Topic

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 21, 2019

First Posted

August 26, 2019

Study Start

September 16, 2019

Primary Completion

April 7, 2020

Study Completion

June 1, 2022

Last Updated

June 30, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations